BioSpace Global Roundup, Oct. 15
The Pharma Data
OCTOBER 14, 2020
VBL Therapeutics – The European Patent Office granted a patent to Israel-based VBL’s proprietary investigational anti-MOSPD2 monoclonal antibodies to treat inflammatory conditions. All jobs have been maintained and the workforce has grown from about 220 to 350. AOP anticipates new opportunities in Austria as a hub for research and business.
Let's personalize your content